Obesity Medicine Association Releases Position Statement: A New Era for Medicare & Medicaid Obesity Medication Coverage [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
Medicaid Coverage and Expanded Access to Obesity Medications, detailing the association's recommendations and support for emerging federal policies expected to dramatically improve treatment access for millions of Americans living with obesity. The OMA commends the Centers for Medicare and Medicaid Services (CMS) and pharmaceutical partners, including Eli Lilly and Novo Nordisk, for collaborating on initiatives that reinforce the recognition of obesity as a chronic disease requiring comprehensive medical treatment. The OMA's position focuses on several critical areas of expansion and improvement, urging policymakers to ensure equitable, affordable, and seamless access to care. While much is likely to change in the coming months to years, the following represents an initial preliminary OMA Position Statement , with a planned follow-up at a later date when policies are more definitive. Medicare Coverage Pilots & Affordability (Starting 2026) The OMA supports the initial pilot of GLP
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- 5 Things to know for Dec. 24: Epstein files, National Guard, Nursing home explosion, Student loans, Weight loss drugs [CNN]CNN
- 5 Things to know for Dec. 24: Epstein files, National Guard, Nursing home explosion, Student loans, Weight loss drugs [CNN]CNN
- Weight-loss pill approval set to accelerate food industry product overhauls [Yahoo! Finance]Yahoo! Finance
- Weight-loss pill approval set to accelerate food industry product overhauls [Yahoo! Finance Canada]Yahoo! Finance Canada
- European markets open higher; Novo Nordisk shares jump 9%, extending rally after GLP-1 pill approval [MSNBC.com]MSNBC.com
NVO
Earnings
- 11/6/25 - Beat
NVO
Sec Filings
- 12/23/25 - Form 6-K
- 11/25/25 - Form 6-K
- 11/24/25 - Form 6-K
- NVO's page on the SEC website